Notice of Intent to Sole Source - Urine Analyzers.pdf

Notice of Intent to Sole Source

HT941025N0147

THIS IS A NOTICE OF INTENT TO AWARD A SOLE SOURCE SUPPLY CONTRACT AND IS NOT A

REQUEST FOR COMPETITIVE QUOTES. The Defense Health Agency Contracting Activity (DHACA), Healthcare Contracting Division – West (HCD-W), San Diego, intends to negotiate and award a firm fixed price contract for the lease, service and consumables for three Arkray urinalysis Systems at NMRTC Yokosuka in accordance with FAR 13.106-1(b)(1)(i), only one source being available to meet the Government’s needs, to:

ARKRAY Marketing, Inc.

Kouhoku, Sinyokohama,3-18-9 Yokohama, JAPAN 222-0033

Items include:

The requirement is for a quantity of three Arkray AE-4060 and AI-4510 urinary sediment bridge systems. The requirement includes the leasing, maintenance, and consumables. The location of all services will be on site at Naval Medical Readiness Training Command (NMRTC) Yokosuka.

The following Arkray consumables are required on a recurring schedule (monthly, quarterly, bi-annually, and annually):

• 73527 – Arkray AutoCheck Plus

• 106846 – Arkray URIFLET 9ub

• 79053 – Arkray Concentrated Washing Solution 3

• 100672 – S.G. Calibrator H

• 106839 – Auto Sticks

• 10067 – Thermal Paper

• 105582 – Auto Eye Sheath Solution

• 105638 – Auto Eye Control Solution

• 105639 – Auto Eye Calibrator

• 106378 – Filter Set

• 10374 – Filter and O-Ring

The contractor shall provide all scheduled and unscheduled maintenance on site at the Government facility for each leased machine. Contractors must submit a comprehensive service report, in English, following each maintenance service.

The North American Industry Classification System (NAICS) code for this requirement is 325413

– In-Vitro Diagnostic Substance Manufacturing; the business size standard is 1,250 employees.

The Product Service Code (PSC) is 6550 - Sets and kits designated for in vitro qualitative and quantitative tests.

Based on market research, Arkray is the sole vendor capable of providing a leasing solution for a urine analyzer bridge system that meets USNMRTC Yokosuka’s requirements.

This notice of intent is not a request for competitive proposals, and no solicitation document exists for this requirement. Sources interested in responding to this notice are required to submit a capability statement that includes management and technical data and cost information, in sufficient detail and with convincing evidence that clearly demonstrates the capability to provide the required services at the above locations and are able to provide valid certification to provide service validated by Rees Scientific Corp. Capability statements shall not exceed four (8.5 x 11 inch) pages using a font size no smaller than 12-point. All capability statements received by the due date of this notice will be considered by the Government. A request for documentation or additional information or submissions that only ask questions will not be considered as an affirmative response. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government.

Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement or to proceed with a sole source purchase order under the authority of FAR 13.5.

If a vendor challenges the basis of this requirement, please email capability statements as a Microsoft Word or Adobe PDF attachment to Shannon La Com at shannon.lacom2.civ@health.mil.

All documents received after the closing date and time of the announcement may not be considered.

NO TELEPHONE REQUESTS/OFFERS WILL BE HONORED.

mailto:shannon.lacom2.civ@health.mil